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Naringenin and hesperetin are two of the most abundant flavanones 
found in citrus with beneficial effects on human health. However, their poor 
water solubility imposes considerable limitations to their use in functional 
foods or nutraceuticals development. In order to increase their aqueous 
solubility and find a new stable system, the effect of different factors as 
temperature, pH or complexation agents as cyclodextrins has been studied. 
The solubility of both flavanones increased exponentially with temperature 
(25-90 ºC): 10-fold in the case of naringenin and 20-fold for hesperetin. The 
solubility of both flavanones also increased with the media pH (3.5-8.5): 
314-fold in the case of naringenin and 3.5-fold for hesperetin. Flavanones 
solubility also increased with β- or HP-β-CDs concentration. By the addition 
of β-CDs 13 mM naringenin solubility increased 9.3-fold and hesperetin 
solubility 30-fold. Using HP-β-CDs 100 mM naringenin solubility increased 
143-fold and hesperetin 467-fold. In summary, the higher increase in 
naringenin solubility was reached by increasing pH up 8.5. However, in the 
case of hesperetin, the higher increase was obtained by complexation with 
HP-β-CDs 100 mM. Moreover, the presence of CDs, not only increased the 
aqueous solubility of flavanones, but also improved the stability of 
hesperetin at pHs 3.5 and 6.5. 
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1. Introduction 
Flavanones are a group of flavonoids that are mainly found in citrus, 
honey, mint and tomato (Tomas-Barberan & Clifford, 2000). Among the 
most abundant flavanones in these foods are naringenin (4', 5, 7-
trihydroxyflavanone) and hesperetin (3', 5, 7 trihydroxy-4-
methoxyflavanone) (Bravo, 1998). In recent years there has been a growth 
in interest in these flavanones due to the beneficial effects attributed to them, 
including their protective role against lipid peroxidation of the membranes 
involved in several physiological and pathological disorders such as aging, 
inflammation, atherosclerosis and ischemia (Harbone & Willian, 2000; 
Kühnau, 1976; Benavente-García & Castillo, 2008; Hollman, Katan, Rice-
Evans & Packer, 1998; Erlejman, Verstraeten, Fraga & Oteiza, 2004). 
In addition, naringenin has been reported to have beneficial biological 
effects on human health as an antioxidant, free radical scavenger, anticancer, 
anti-inflammatory or immunomodulatory agent, and memory enhancer 
(Erlun, 2004; Julian, Moyano, Yañez, olea-Azar, 2007; Burdock, 1998). In 
recent years, naringenin has been found to have a neuroprotective effect in 
the ICV-STZ induced model of Alzheimer’s disease, 6-OHDA model of 
Parkinson’s disease or scopolamine-induced amnesia, and to prevent 
oxidative damage in various pathophysiological conditions due to its ability 
to penetrate into the brain (Pratico, 2008); Kakkar & Dahiya, 2015; Noble & 
Burns, 2010). 
For its part, hesperidin also has antioxidant, bone-sparing and lipid-
lowering effects and plays a significant role in inflammation and cancer 
inhibition. Its antioxidant property, together with the ability to cross the 
blood–brain barrier, seems to contribute to neuroprotection against oxidative 
damage (Salas, Céliz, Geronazzo, & Daz, 2011). 
As a result, there is a growing interest in using flavonoids to enrich 
food products in order to enhance their health functions, as well as in 
developing flavonoid-based nutraceutical and pharmaceutical products. 
However, the very poor water solubility of these flavanones imposes 
considerable limitations to their use (Guo, Tang, Lu, Fang, Tu & Zheng, 
2018). So, it is necessary to develop new formulations that incorporate 
naringein and hesperetin in foods to improve their solubility and in vivo 
bioavalilability. Nanoencapsulation (formation of molecular complexes) can 
overcome the low water solubility and bioavailability of poor water-soluble 
compounds, and the high demand to produce foods with additional 
nutritional value led to many applications of nanoencapsulation in functional 
food development. 
In recent years, complexation with cyclodextrins (CDs) has been 
successfully used to improve the solubility, chemical stability and 
bioavailability of a number of poorly soluble compounds, including, 
flavonoids (Kin, Kim & Jung, 2008; Lucas-Abellán, Fortea, Gabaldón-
Hernández, & Núñez-Delicado, 2008a, Lucas-Abellán, Fortea, Gabaldón-
Hernández, & Núñez-Delicado, 2008b; López-Nicolás, Núñez-Delicado, 
Pérez-López, Carbonell-Barrachina & Cuadra-Crespo, 2006). The formation 
of molecular complexes with CDs could be one way to improve the water 
solubility of flavonoids. CDs are cyclic oligosaccharides consisting of six (α-
CDs), seven (β-CDs), eight (γ-CDs) or more glucopyranose units linked by 
α (1-4) bonds and adopting a truncated cone structure with an internal 
hydrophobic cavity (Martín Del Valle, 2004). They are produced as a result 
of intramolecular transglycosylation reactions through the degradation of 
starch by cyclodextrin glucanotransferase (CGTase) (Szetjili, 1998). 
Compared with water, the internal cavity of CDs is relatively hydrophobic, 
while the outer surface is hydrophilic. This characteristic enables CDs to 
form inclusion complexes with a variety of compounds (Loftsson & 
Brewster, 1996; Szetjli, 1998; Zyzelewicz, Oracz, Kaczmarska, Budryn & 
Grzelczyk, 2018). Indeed, CDs have been used as complexing agents to 
increase the water solubility of many compounds, such as drugs, vitamins or 
food colorants (Fujishima, Kusaka, Umino, Urushinata & Terumi, 2001; 
Bhardwaj, Dorr & Blanchard, 2000), and it has been demonstrated that 
complexation can considerably increase the water solubility, stability and 
bioavailability of many guest molecules. 
The objective of this paper was to study the aqueous solubility and 
stability of two flavanones, naringenin and hesperetin in different conditions 
of temperature, pH and also in the presence of natural complexing agents as 
CDs. The effect of temperature, pH and complexation with β-cyclodextrins 
(β-CDs) or hydroxy-propyl-β-cyclodextrins (HP-β-CDs) on the aqueous 
solubility and stability of these flavanones were studied in an attempt to 
develop a new system in which they could be solubilized in a stable way for 
use in food or pharmaceutical applications. In order to characterize the 
complexation process and determine the best cyclodextrin type to complex 
each flavanone, complexation constant (Kc), complexation efficiency (CE) 
and molar ratio were calculated in each case. 
2. Materials and methods 
Naringenin and hesperetin (assay > 90% purity) were kindly provided 
by Nutrafur S.A. (Murcia, Spain). β-CDs and HP-β-CDs were purchased 
from Henan Puertai Animal Medicine Co. (Zhengzhou, China). HPLC-grade 
acetonitrile and double-distilled HPLC-grade water was supplied from 
Aldrich (Madrid, Spain). All other chemicals used were of analytical grade.  
2.1. Effect of temperature on aqueous solubility of the flavonones 
An excess amount of naringenin (30 mg) or hesperetin (30 mg) was 
added to 10 mL of water. The mixtures were shaken in an ultrasonic bath at 
different temperatures (20, 25, 30, 35, 40, 50, 70 and 90 ºC) and for different 
times (5, 15, 30, 45 and 60 min). Undissolved naringenin or hesperetin was 
removed by filtering through 0.45 μm acetate cellulose filters. The 
concentration of naringenin or hesperetin in the clear filtrate was determined 
spectrophotometrically at 290 (ε290=17.51 M-1cm-1) or 292 (ε292=34.38 M-
1cm-1) nm, respectively.  
2.2. Effect of pH 
An excess amount of naringenin (30 mg) or hesperetin (30 mg) was 
added to 10 mL of 100 mM sodium acetate buffer pH 3.5, 100 mM sodium 
phosphate buffer pH 6.5, or 100 mM sodium borate buffer pH 8.5. The 
mixtures were shaken in an ultrasonic bath for 60 min. After that, 
undissolved naringenin or hesperetin was removed by filtration thought 0.45 
µm acetate cellulose filter and the flavanone concentrations were determined 
as described in section 2.1. In order to improve the assay accuracy and 
standardizing the measure procedure, in all cases, the concentration of 
naringenin or hesperetin were quantified at 290 or 292 nm with samples 
diluted with ethanol 80%, minimizing thus the possible variation in the 
absorbance due to the pH effect. 
2.3. Effect of CDs on aqueous solubility of flavanones. 
Phase solubility diagrams were constructed according to Higuchi & 
Connors (1965) with some modifications. Excess amounts of each flavanone 
were added to aqueous solutions with increasing concentrations of β- or HP-
-CDs up to 13 or 100 mM, respectively, in 10 mL of 100 mM sodium 
acetate buffer (pH 3.5), 100 mM sodium phosphate buffer (pH 6.5) or 100 
mM sodium borate buffer (pH 8.5). The samples were maintained in an 
ultrasonic bath at 25 ºC for 60 min to reach equilibrium. The aqueous 
solutions were then filtered through 0.45 µm acetate cellulose membrane 
filter and diluted in 80% ethanol before flavanone quantification. Naringenin 
or hesperetin concentration in each clear filtrate was spectrophotometrically 
determined by measuring at their wavelength maximum. 
The complexation constant (Kc) between naringenin or hesperetin and 









where S0 is the water solubility of the flavanone, and “slope” the slope of the 
phase solubility diagram. 
2.4. Stability tests 
The stability of naringenin and hesperetin in aqueous solution at 
different pHs (3.5, 6.5 and 8.5) was studied at 25 ºC. For this purpose, a 1 ml 
aliquot of naringenin or hesperetin solution (1 mg/mL in 80 % ethanol) was 
mixed with 5 ml of buffer solution (13 % ethanol) containing (or not) 6 mM 
of CDs (β- or HP-β-CDs). At different time intervals, the remaining 
[1] 
naringenin or hesperetin concentration was determined by HPLC (Hewlett-
Packard Series HP 1100 equipped with a diode array detector). The 
stationary phase was a C18 LiChrospher 100 analytical column (250 x 4 mm 
i.d.) with a particle size of 5 µm (Merck, Darmstadt, Germany) thermostatic 
at 30 ºC. The mobile phase consisted of acetonitrile/water (60/40) with a 1 
mL/min flow rate, and the injection volume was 20 µL. Naringenin or 
hesperetin was detected at 290 or 292 nm, respectively and they were 
quantified buy using a calibration curve from 0.005 to 0.05 mM prepared in 
ethanol 80%. 
  
3. Results and discussion 
 The purpose of this paper was to study the solubility and stability of 
naringenin and hesperetin in aqueous solution at different pHs and 
temperatures and the effect of their inclusion in native β- or their modified 
HP-β-CDs on the aqueous solubility and stability of these compounds at 
different pH values.  
3.1. Effect of temperature on aqueous solubility 
Because naringenin and hesperetin are poorly soluble in water, the 
effect of temperature on their aqueous solubility was studied by means of a 
solubility test at 20, 25, 30, 35, 40, 50, 70 and 90 ºC in sodium phosphate 
buffer 100 mM pH 6.5.  
As can be seen in Figure 1, the solubility of naringenin and hesperertin 
at 25 ºC was only 0.14±0.03 mM (Figure 1A) and 0.03±0.01 mM (Figure 
1B), respectively, indicating their poor aqueous solublility. However, their 
solubility increased exponentially with temperature, suggesting that the 
process is thermodynamically favorable, at 90 ºC reaching a concentration 
of 1.5±0.04 mM for naringenin (10-fold higher than at 25 ºC) and 0.6±0.02 
mM for hesperetin (20-fold higher than its aqueous solubility at 25 ºC). 
The lower aqueous solubility of hesperetin at all the temperatures 
assayed was due to the presence of the –CH3 group in 4’C position. 
3.2 Effect of pH in aqueous solubility 
The solubility of naringenin and hesperetin was also affected by the 
pH of the medium used, increasing from 9·10-3±2·10-3 mM at pH 3.5 to 
2.83±0.18 mM at pH 8.5 (314-fold) in the case of naringenin; and from 
0.02±0.01 mM at pH 3.5 to 0.07±0.02 at pH 8.5 (3.5 fold) for hesperetin 
(Table 1). 
The more pronounced increase in the solubility of naringenin with 
increasing pH was due to the chemical structure associated with the 
deprotonated form of the three –OH groups. However, in the case of 
hesperetin, the presence of the –CH3 group in 4´C position leads to the 
formation of a less resonant structure at pH 8.5 and thus a less soluble form. 
3.3. Effect of complexation in CDs 
After studying the effect of temperature and pH on the solubility of 
naringenin and hesperetin, the effect of the presence of β- or their modified 
HP-β-CDs at 25 ºC was also investigated by developing phase solubility 
diagrams. 
As can be seen in Figure 2 either flavanones concentration increased 
linearly with β- (Figure 2A) or HP-β-CDs (Figure 2B) concentration. In the 
case of β-CDs, due to their low aqueous solubility, the maximum CDs 
concentration used was 13 mM (Figure 2A). Naringenin solubility increased 
from 0.14±0.03 (S0) to 1.3 mM with 13 mM β-CDs (9.3-fold) (Figure 2A, ●) 
and hesperetin from 0.03±0.01 (S0) to 0.75 mM with 13 mM β-CDs (25-fold) 
(Figure 2A, ○). In the case of HP-β-CDs, due to their higher aqueous 
solubility, the CDs concentration used could reach 100 mM (Figure 2B). 
Naringenin solubility increased from 0.14±0.03 to 23±0.1 mM with HP-β-
CDs at 100 mM (164-fold) (Figure 2B, ●) and from 0.03±0.01 to 14±0.05 
mM in the case of hesperetin (467-fold) (Figure 2B, ○). 
Comparing the results obtained by using different CDs with those 
obtained by increasing temperature or pH (Figure 3), the increase in the 
solubility of both flavanones obtained with 100 mM HP-β-CDs was much 
greater than that obtained by increasing the temperature from 20 to 90 °C 
(164-fold vs. 10.7-fold for naringenin and 467-fold vs. 20 fold for hespertin). 
In the case of β-CDs the increase in aqueous solubility was similar to that 
obtained by increasing the temperature from 20 to 90 ºC for both types of 
flavanones (9.3-fold vs. 10.7-fold for naringenin and 25-fold vs. 20-fold for 
hesperetin). 
Increasing the pH from 3.5 to 8.5 led to a 314-fold increase in 
naringenin solubility, a greater increase than was obtained by using 100mM 
HP-β-CDs (143-fold). However, in the case of hesperetin, the increase in 
solubility due to de pH change was only 3.5-fold vs 467-fold observed with 
100 mM HP-β-CDs (Figure 3). 
Note that at the same concentration (13 mM), HP-β-CDs increased the 
aqueous solubility of both flavanones to a greater extent than β-CDs (Figure 
3). 
The phase solubility plots for the flavanone-CDs complexes displayed 
typical AL diagrams, that is to say, a linear increase in flavanone solubility 
with increasing CDs concentration (β- and HP-β-CDs) (Figures 2A and 2B). 
The slope values lower than 1 point to a 1:1 stoichiometry for the complexes 
formed between naringenin or hesperetin and β- or HP-β-CDs. 
The Kc values obtained for both naringenin and hesperetin were 
higher in the case of HP-β-CDs (1,786±185 M-1 for naringenin and 
4,651±525 M-1 for hesperetin) (Pérez-Abril et al. 2017) than in the case of β-
CDs (681±77 M-1 for naringenin and 1,123±101 M-1 for hesperetin), at pH 
6.5 (Table 1). These results indicate that the complexes formed between each 
naringenin or hesperetin, and HP-β-CDs were much more stable than those 
formed with β-CDs. The addition of hydroxypropil groups to native β-CDs 
favored the entrapment of naringenin or hesperetin in the hydrophobic cavity 
of the CDs. This phenomenon has also been demonstrated in the case of other 
flavonoids such as resveratrol (Lucas-Abellán, Fortea, Gabaldón-Hernández, 
& Núñez-Delicado, 2008a; Lucas-Abellán, Fortea, Gabaldón-Hernández, & 
Núñez-Delicado, 2008b; Mercader-Ros, Lucas-Abellán, Gabaldón, Fortea, 
Martínez-Cachá, & Núñez-Delicado, 2010). 
The Kc values obtained represented the strength of the interaction 
between each flavanone and β- or HP-β-CDs, making it possible to compare 
the affinity between each one and native or modified CDs. However, to study 
the solubility effect of CDs on naringenin and hesperetin in greater depth, 
their complexation efficiency (CE) values were calculated. The CE 
represents the molar ratio between complexed and the free CDs 
concentration (Loftsson & Duchêne., 2007). Taking into account both the 
aqueous solubility of the flavanone and the Kc value, for 1:1 stoichiometry 
complexes, the CE was calculated from the slope of the phase solubility 
diagram using equation [2] (López-Miranda, Guardiola, Hernánrdez-
Sánchez & Núñez-Delicado, 2017) 
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where [F-CDs] is the soluble complex concentration, [CDs] is the dissolved 
free CDs concentration and slope is the slope of the phase solubility diagram. 
The CE values obtained for naringenin and hesperetin with β- or HP-
β-CDs are shown in Table 1. Comparing the CE values obtained for each 
flavanone rather than the Kc values is more convenient when different types 
of CDs and experimental conditions are being compared. As can be seen in 
Table 1, the CE values obtained at pH 6.5 for both naringenin and hesperetin 
were higher with HP-β- than for β-CDs. In the case of naringenin, the CE 
value obtained for β-CDs was 9.5% and for HP-β-CDs 25% (2.6-fold 
higher). In the case hesperetin, the CE value obtained for β-CDs was 3.4% 
while for HP- β-CDs it was 13.9% (4.1-fold higher). 
The CE values were also used to calculate the molar ratio in solution 
of naringenin:CDs or hesperetin:CDs, the value of which would reflect the 
expected increase in naringenin or hesperetin solubility with different types 
of CDs (Equation [3]) (Loftson & Duchêne, 2007): 
𝐹𝑙𝑎𝑣𝑎𝑛𝑜𝑛𝑒: 𝐶𝐷𝑠 = 1:(1 +
1
𝐶𝐸
)    [3] 
The values of the molar ratio obtained for naringenin and hesperetin 
with β- or HP-β-CDs are shown in Table 1. At pH 6.5, the molar ratio of the 
solution showed that HP-β-CDs was the most effective because about one in 
5 CDs molecules in solution formed water soluble complexes with 
naringenin, whereas in the case of β-CDs the ratio was about one in 11 (Table 
1). In the case of hesperetin, the results obtained were similar to those 
obtained for naringenin, HP-β-CDs being more effective than β-CDs (1:31 
for β-CDs and 1:8 for HP-β-CDs) (Table 1).  
In summary, HP-β-CDs were more effective for the complexation of 
naringenin and hesperetin than β-CDs at pH 6.5, as indicated by the CE 
values and molar ratio (Table 1). Moreover, complexes formed by HP-β-CDs 
were more stable, as indicated by the Kc values (Table 1). Of the two 
flavanones, hesperetin formed more stable complexes with β- or HP-β-CDs 
than naringenin (Kc hesperetin >Kc naringenin, for both β- and HP-β-CDs) 
(Table 1), probably because the presence of the -CH3 group in 4´position 
makes hesperetin more hydrophobic than naringenin, thus increasing the Kc 
values for both types of CDs (Table 1). 
However, naringenin was the flavanone most effectively complexed 
by both types of CDs (CE naringenin>CE hesperetin, for both β- and HP-β-
CDs) at pH 6.5 and 8.5 (Table 1), because this parameter represented the 
ratio between complexed and free CDs. Moreover, CE is obtained by the 
product between Kc value and S0. Hence, a decrease in S0 would be expected 
to involve a lower CE value, as was the case with hesperetin. 
3.3. Effect of pH on the complexation process 
The effect of acid (3.5) or basic (8.5) pH on the complexation of the 
flavanones (naringenin and hesperetin) with β- or HP-β-CDs was also 
studied.  
The pH value determines the presence (or not) of protonated flavanone 
forms in the solution, influencing their aqueous solubility and also the 
complexation process. At both pH values studied (3.5 and 8.5), the phase 
solubility diagrams obtained were AL type with a slope of less than 1, 
indicating the 1:1 stoichoimetry of the complexation formed between 
naringenin or hesperetin and β- or HP-β-CDs (Figure 4). The Kc values 
obtained from the phase solubility diagrams for both, naringenin or 
hesperetin were higher at acid or neutral pH than at basic pH (Table 1). These 
results indicated that the protonated forms of each flavanone formed more 
stable complexes with β- or HP-β-CDs than the corresponding deprotonated 
forms. The significant decrease in the Kc value at basic pH (8.5) was also 
due to the characteristic balance existing in these compounds between the 
flavanone (closed C ring) and chalcone (open ring C) forms begins to move 
significantly towards the chalcone form, at basic pH with higher aqueous 
solubility S0 (from 9.10-3±2.10-3 mM at pH 3.0 to 2.83±0.18 mM at pH 8.5 
in the case of naringenin and from 0.02±0.02 mM at pH 3.0 to 0.07±0.02 
mM at pH 8.5 in the case of hesperetin) (Table 1). The pronounced increase 
in the aqueous solubility of naringenin as the pH increased from pH 3.0 to 
8.5 implied a drastic decrease in the Kc value, both in the presence of β- 
(from 1085±108 M-1 at pH 3.5 to 184±44 M-1 at pH 8.5) and HP-β-CDs (from 
1515±223 M-1 at pH 3.5 to 225±37 M-1 at pH 8.5) (Table 1). The Kc value 
obtained for naringenin and β-CDs at pH 3.0 was in the same order to that 
obtained by Yang et al. in 2013 (Yang, Ma, Zhou, Chen, Yuan, Yin & Yang, 
2013). 
As can be seen in the results presented in Table 1, the Kc values 
obtained for naringenin or hesperetin at both pH 3.5 and 6.5 were higher 
following complexation with modified HP-β-CDs than with the parental β-
CDs, indicating the formation a more stable complex with HP-β-CDs. 
However, at basic pH (8.5), the increase in solubility of flavanones due to 
the presence of the chalcone form, masked the effect of interaction between 
HP-β-CDs and the flavanone, so that the Kc value did not increase so much 
as might be expected. 
As the aqueous solubility of flavanones and Kc values varied with the 
pH of the medium, both the CE and molar ratio were also affected by this 
parameter. In the case of naringenin, the CE clearly increased with the pH 
for both β- (from 0.9 % at pH 3.5 to 52 % at 8.5) and HP-β-CDs (from 1.4 
% at pH 3.5 to 63.7 % at pH 8.5) (Table 1). In the case of hesperetin, the CE 
values increased but to a lesser extent than with β-CDs (from 1.9 % at pH 
3.5 to 22.9 % at pH 8.5) and decreased for HP-β-CDs (from 7.1 % at pH 3.5 
to 2.8 % at pH 8.5) (Table 1). The highest CE values obtained were 63.7 % 
and 52 % for naringenin complexation at pH 8.5 with HP-β- and β-CDs, 
respectively, indicating that at this basic pH, one in every 3 β- or HP-β-CDs 
molecules in solution forms water soluble complexes with naringenin (molar 
ratio 1:3) (Table 1). 
3.3. Stability of naringenin and hesperetin in aqueous solution 
The stability of naringenin and hesperetin in aqueous solution at 
different pHs (3.5, 6.5 and 8.5) was also studied.  
As can be seen in Figure 5A, the naringenin concentration in aqueous 
solution remained stable for 48 hours at all the pHs studied (3.5, 6.5 and 8.5). 
In the case of hesperetin (Figure 5B), its stability was affected with time at 
pH 3.5 and pH 6.5, but remained constant at pH 8.5. In order to establish 
whether the loss of hesperetin with time at pH 3.5 and 6.5 was due to its 
transformation into another compound or to the precipitation of the 
flavanone, the chromatographic profile of the solution was analyzed. As can 
be seen in Figure 6, the hesperetin chromatogram profile did not change with 
time at pH 3.5 or 6.5, indicating that the loss of the compound was due to its 
precipitation because of its low solubility at both pHs. At basic pH (8.5), 
hesperetin solubility increased significantly due to a change in the chalcone-
flavanone structure with higher aqueous solubility increasing its stability. 
The stability of naringenin and hesperetin were also studied in 
buffered media at different pHs (3.5, 6.5 and 8.5) in the presence of β- or 
HP-β-CDs. In the case of naringenin, it was stable for 48 h in the presence 
of CDs (Figure 5C and 5E), as in the absence (Figure 5A). With respect to 
hesperetin, the presence of β- or HP-β-CDs permitted the stabilization of the 
flavanone at pHs 3.5 and 6.5 (Figures 5D and 5F) due to the complexation 
of hesperetin in the hydrophobic cavity of native or modified CDs, increasing 
the aqueous solubility.  
  
4. Conclusion  
This paper shows that flavanones aqueous solubility and stability are 
affected by temperature, pH and the presence of complexating agents as CDs 
in the media, being HP-β-CDs the most effective agents to increase these 
properties. Moreover, β- and HP-β-CDs form 1:1 complexes with naringenin 
and hesperetin. The results obtained indicated that the highest Kc value did 
not always correspond to the highest CE because of the influence of the 
aqueous solubility (S0) of the flavanone on both values. For this reason, it is 
more accurate to use the CE value to study the effect of pH on the 
complexation process of flavanones. In the case of naringenin and 
hesperetin, the deprotonated form of naringenin at pH 8.5 was the most 
efficiently encapsulated by β- and HP-β-CDs, whereas the protonated form 
of hesperetin at pH 6.5 formed the strongest complexes with HP-β-CDs, and 
had the highest Kc value. Moreover, the complexation process improved the 
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pH 3.5  
Molar 
Ratio 

















Naringenin 9 ·10-3 ± 2 ·10-3 
1085±108 0.9 1:103 0.14 ± 0.03 681 ± 77 9.5 1:11 2.83 ± 0.18 184  ± 44 52 1:3 
Hesperetin 
0.02 ± 0.01 932  ± 189 1.9 1:55 0.03 ± 0.01 1123 ± 101 3.4 1:31 0.07 ± 0.02 410± 41 22.9 1:36 
HP-β-CDs 
Naringenin 9 ·10-3 ± 2 ·10-3 
1515 ± 223 1.4 1:74 0.14 ± 0.03 1786 ± 385 25 1:5 2.83 ± 0.18 225 ± 37 63.7 1:3 
Hesperetin 
0.02 ± 0.01 3546 ± 216 7.1 1:15 0.03 ± 0.01 4651 ±525 13.9 1:8 0.07 ± 0.02 403 ± 29 2.8 1:36 
 
Table 1 
Aqueous solubility, Kc, CE and Molar Ratio of flavanones at different pH values with β- and HP-β-CDs 
 
  
Figure 1: Effect of temperature on the solubility of the flavanones 




















































Figure 2: Phase of solubility diagram of naringenin () and hesperetin () 
sodium phosphate buffer 100 mM (pH 6.5) with -CDs (A) and 
HP--CDs (B).  
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Figure 3:  Solubility of naringenin and hesperetin at different temperatures 
and with different types of CDs 
 
  




















Figure 4: Phase of solubility diagrams of naringenin () and hesperetin () 
in 100 mM sodium acetate buffer (pH 3.5) with - (A) or HP-
-CDs (B) and 100 mM sodium borate buffer (pH 8.5) with - 






















































































Figure 5: Time course for loss of naringenin (A) and hesperetin (B), naringenin with -
CDs (C), hesperetin with -CDs (D), naringenin with HP--CDs (E) and 
hesperetin with HP--CDs (F) in different solution media 100 mM sodium 
acetate buffer (pH 3.5) (), 100 mM sodium phosphate buffer (pH 6.5) 
() and 100 mM sodium borate buffer (pH 8.5) (). 
Tiime(min)

















































































































Figure 6: (A) Chromatogram of hesperetin in aqueous solution 100 mM sodium acetate 
buffer (pH 3.5) at 1h (-) and 48h (...). (B) The chromatogram of hesperetin 
in aqueous solution 100 mM sodium phosphate buffer (pH 6.5) at 1h (-) 
and 48h (...). 
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